Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice
Background. Parkinson’s disease psychosis (PDP) is a common, nonmotor symptom of Parkinson’s disease (PD), which may affect up to 60% of patients and is associated with impaired quality of life, increased healthcare costs, and nursing home placement, among other adverse outcomes. Characteristic symp...
Saved in:
Main Authors: | Khashayar Dashtipour, Fiona Gupta, Robert A. Hauser, Cherian A. Karunapuzha, John C. Morgan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2021/2603641 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psychosis in Parkinson's disease in a Southeast Asian cohort: prevalence and clinical correlates
by: Vanessa Wai Ling Mok, et al.
Published: (2022-12-01) -
Comments on: Psychosis in Parkinson’s disease in a Southeast Asian cohort: prevalence and clinical correlates
by: Neal Jain, et al.
Published: (2023-05-01) -
Iron Accumulation Is Not Homogenous among Patients with Parkinson’s Disease
by: Khashayar Dashtipour, et al.
Published: (2015-01-01) -
Novel Pattern of Iron Deposition in the Fascicula Nigrale in Patients with Parkinson’s Disease: A Pilot Study
by: Miriam E. Peckham, et al.
Published: (2016-01-01) -
Psychosis as an Isolated Manifestation of COVID-19 in Non-Demented Patients with Parkinson's Disease: Clinical Cases and Literature Review
by: G. Lokominaitė, et al.
Published: (2023-11-01)